In last trading session, Black Diamond Therapeutics Inc (NASDAQ:BDTX) saw 0.39 million shares changing hands with its beta currently measuring 2.49. Company’s recent per share
During the last session, Black Diamond Therapeutics Inc (NASDAQ:BDTX)’s traded shares were 0.43 million, with the beta value of the company hitting 2.49. At the
Black Diamond Therapeutics Inc (NASDAQ:BDTX)’s traded shares stood at 0.49 million during the last session, with the company’s beta value hitting 2.49. At the close
During the last session, Black Diamond Therapeutics Inc (NASDAQ:BDTX)’s traded shares were 0.71 million, with the beta value of the company hitting 2.52. At the
During the last session, Black Diamond Therapeutics Inc (NASDAQ:BDTX)’s traded shares were 1.3 million, with the beta value of the company hitting 2.52. At the
In the latest trading session, 1.11 million Black Diamond Therapeutics Inc (NASDAQ:BDTX) shares changed hands as the company’s beta touched 2.48. With the company’s most
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
